• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Public Health . Pediatric practice experiences with second dose influenza vaccination: An AAP Pediatric Research in Office Settings (PROS) Study

tetano

Editor, Senior Moderator
Public Health


. 2024 Aug 21:236:93-98.
doi: 10.1016/j.puhe.2024.07.018. Online ahead of print. Pediatric practice experiences with second dose influenza vaccination: An AAP Pediatric Research in Office Settings (PROS) Study

C S Wynn[SUP] 1 [/SUP], M S Stockwell[SUP] 2 [/SUP], E Nekrasova[SUP] 3 [/SUP], A Torres[SUP] 4 [/SUP], M Griffith[SUP] 4 [/SUP], S S Kumar[SUP] 3 [/SUP], L P Shone[SUP] 4 [/SUP], R Localio[SUP] 5 [/SUP], J Shults[SUP] 5 [/SUP], R Unger[SUP] 6 [/SUP], L A Ware[SUP] 7 [/SUP], A G Fiks[SUP] 3 [/SUP]



Affiliations
Abstract

Objectives: Explore pediatric staff experiences administering the second influenza vaccine dose.
Study design: Qualitative focus groups/interviews.
Methods: As part of the National Institutes of Health-funded Flu2Text randomized control trial of text message reminders for second influenza vaccine dose, we conducted seven focus groups and four individual interviews (n = 39 participants total) with clinicians and staff from participating practices from the American Academy of Pediatrics' Pediatric Research in Office Settings (PROS) Network. Of 37 participating practices, 10 were selected through stratified sampling of practices with highest (n = 5) and lowest (n = 5) randomized controlled trial effect sizes. A semi-structured discussion guide included questions that addressed parental, practice, and health system barriers/facilitators to second influenza vaccine dose administration. Using the Systems Model of Clinical Preventive Care as a conceptual framework, two investigators independently coded transcripts (Κ = 0.86, high agreement) with NVivo 12 Plus. Coding inconsistencies were resolved by consensus.
Results: Clinicians/staff reported that administering the second influenza vaccine dose in a season was more complex than other childhood vaccines. They highlighted parental uncertainty about the need for the second dose and the difficulty and inconvenience of bringing children back to the office as important barriers. Caregiver-staff relationships were perceived as helpful in getting children vaccinated with their second dose and vaccine reminders were seen as important cues-to-action.
Conclusions: Ensuring receipt of two doses of the influenza vaccine in a given season presents unique challenges. Themes identified provide a framework for understanding opportunities to bolster second dose receipt, including explaining why two doses are needed, offering flexible hours for vaccination, and sending vaccine reminders.

Keywords: Childhood vaccine; Influenza clinics; Influenza vaccine; PROS; Pediatric primary care; Vaccine education.

 
Back
Top Bottom